Mayo Clinic Gastrointestinal Cancers Current and Emerging Strategies in Multidisciplinary Care: Translating Evidence into Best Practices 2018
- Venue: Hyatt Regency La Jolla at Aventine
- Location: San Diego View Map
- Start Date: March 1, 2018
- End Date: March 3, 2018
- CME Accredited: Yes
- Places Available: 100
- Click Here to Visit Website...
This course will focus on case-based and didactic presentations from Mayo Clinic and other international experts in the treatment of the whole spectrum of gastrointestinal (GI) cancers including esophageal, gastric, hepatocellular, pancreatic, small bowel, bile duct, anal and colorectal, and gallbladder.
The primary goal of this course is to guide practicing physicians on integrating the best and most current evidence into their day to day routine care for patients with GI cancers. This course will also bring a practical perspective on how to optimize multidisciplinary care for some of the more complex clinical management decisions in GI oncology including but not limited to: locoregional modalities, the role of minimally invasive procedures, and state of the art radiation modalities.
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibiting at this course, please complete Exhibitor Documents and submit to Kristy Badder.
This course is designed for Medical Oncologists, Radiation Oncologists, Surgical Oncologists, GI surgeons, Gastroenterologists and Hepatologists involved in cancer care, Interventional Radiologists, Pharmacists, Nurse Practitioners, Physician Assistants, and Nurses.
Upon conclusion of this program, participants should be able to:
- Interpret the most up-to-date and practice-relevant data presented at various cancer-related meetings in 2017.
- Integrate evidence-based treatment interdisciplinary strategies into clinical practice in various fields of medical oncology.
- Determine the usefulness of biomarker-based treatment approaches in oncology.
- Determine the current and future role of immunotherapy strategies in various GI malignancies.
- Select the appropriate treatment strategy for patients with early stage cancers of GE junction, rectum, pancreas, and liver.
- Identify ideal patients with hepatobiliary cancers and neuroendocrine tumors that would be candidates for transplant.
- Describe the molecular biology and genetics of colorectal cancers.
- Integrate statistical knowledge into the interpretation of published and presented data.
- Select the appropriate regimens for sequencing therapies across multiple GI malignancies.
If you would like to register for this conference, or obtain further information or a letter of invitation to this conference, please follow the links above. TheConferenceWebsite service does not accept bookings for conferences, travel arrangements, housing or accommodation. Please follow the links above for the relevant conference information.Join TheConferenceWebsite here for more Conferences in your Medical Specialty